The government will soon announce the first 10 medications that will be subject to price negotiations with Medicare under a new law. Drugmakers are fighting the measure in court.
Johnson & Johnson has sued four doctors who published studies citing links between talc-based personal care products and cancer, escalating an attack on scientific studies that the company alleges are inaccurate.
Cancer physician groups have become increasingly vocal in recent weeks about national shortages in key medications, including longtime generic drugs like carboplatin and cisplatin.